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Several pathologic conditions are associated with hemolysis,
i.e. release of ferrous (Fe(II)) hemoglobin from red blood cells.
Oxidation of cell-free hemoglobin produces (Fe(III)) methemo-
globin. More extensive oxidation produces (Fe(III)/Fe(IV)AO)
ferryl hemoglobin. Both cell-free methemoglobin and ferryl
hemoglobin are thought to contribute to the pathogenesis of
hemolytic disorders. We show hereby that ferryl hemoglobin,
but not hemoglobin or methemoglobin, acts as a potent proin-
flammatory agonist that induces vascular endothelial cells in
vitro to rearrange the actin cytoskeleton, forming intercellular
gaps and disrupting the integrity of the endothelial cell mono-
layer. Furthermore, ferryl hemoglobin induces the expression of
proinflammatory genes in endothelial cells in vitro, e.g. E-selec-
tin, Icam-1, and Vcam-1, through the activation of the nuclear
factor B family of transcription factors. This proinflammatory
effect, which requires actin polymerization, involves the activa-
tion of the c-Jun N-terminal kinase and the p38 mitogen-acti-
vated protein kinase signal transduction pathways. When
administered to naïve mice, ferryl hemoglobin induces the
recruitment of polymorphonuclear cells, demonstrating that it
acts as a proinflammatory agonist in vivo. In conclusion, oxi-
dizedhemoglobin, i.e. ferryl hemoglobin, acts as a proinflamma-
tory agonist that targets vascular endothelial cells.
Hemoglobin (Hb) is a tetrameric (22) hemoprotein that
accounts for 97% of the total dry content of red blood cells in
mammals, where it acts essentially as a gas sensor/carrier (for
review, see Ref. 1). When confined inside red blood cells, 22
Hb tetramers are kept in a reduced (Fe(II)/ferrous) form (for
review, see Ref. 1). However, there are a variety of pathological
conditions, e.g.malaria (caused by Plasmodium infection), den-
gue hemorrhagic fever (caused by Flavivirus infection), trauma,
ischemia reperfusion injury, organ transplantation, renal fail-
ure, sickle cell anemia, or thalassemias, that are associated with
hemolysis (for review, see Ref. 2). When hemolysis occurs, cell-
free Hb 22 tetramers dissociate into  dimers, which are
oxidized into ferric (Fe(III)) Hb, i.e. methemoglobin (MtHb)7
(3, 4). Sustained exposure of cell-free Hb to reactive oxygen
species, e.g.H2O2, can lead to the formation of (Fe(IV)AO)Hb,
referred to here as ferrylHb (5, 6). This unstable oxidized form
of Hb can return to the ferric (Fe(III)) state through protein
electron transfer in which tyrosine 42 in the Hb  chains acts as
a redox center, cycling between the tyrosine and the tyrosyl
radical while delivering electrons to ferryl heme (6–8). Tyrosyl
radicals can form covalent dityrosine bonds leading to inter-
and intramolecular cross-linking and to ferrylHb polyme-
rization (7, 9). In addition, tyrosyl radicals can catalyze other
reactions, in which oxidation products are released via frag-
mentation and/or proteolysis (10). Although ferrylHb is
thought to act in a pro-oxidant and cytotoxic manner (11) its
pathophysiological effects remain poorly understood. We
reasoned that because of the physical location at the inter-
face between blood and tissues, vascular endothelial cells
(EC) might be the main cellular target for putative patho-
physiological effects of ferrylHb.
Under inflammatory conditions EC become activated,
promoting vasoconstriction and thrombosis as well as
leukocyte chemotaxis, adhesion, and transmigration (for
review, see Ref. 12). This proinflammatory response results
from the expression of immediate-early responsive genes
encoding vasoconstrictive (e.g. endothelin 1/2), pro-throm-
botic (e.g. tissue factor), proinflammatory (e.g. interleukin-1
and -6), and chemotactic (e.g. interleukin-8) as well as adhesive
(e.g. intercellular adhesion molecule 1 (ICAM-1/CD54), vascu-
lar cell adhesion molecule 1 (VCAM-1/CD106), E-selectin/
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CD62E, and P-selectin/CD62P molecules (for review, see Ref.
12). Expression of these genes is regulated primarily at the tran-
scriptional level via activation of the nuclear factor  B (NF-B)
family of transcription factors (13, 14).
NF-B comprises five family members, i.e. NF-B1/p105,
NF-B2/p100, RelA/p65, RelB, and c-Rel that can form active
homo- or heterodimers (for review, see Ref. 15). Under home-
ostasis, these NF-B dimers are kept in an inactive form based
on their constitutive sequestration by cytoplasmic inhibitors of
NF-B molecules, namely IB (16), IB, IB IB, and
Bcl-3 (for review, see Ref. 15). Most proinflammatory agonists
that elicit EC activation target IB molecules for phosphoryla-
tion (17), ubiquitination (18), and proteolytic degradation by
the 26 S proteasome pathway (19, 20). This allows for rapid
nuclear translocation and binding of theNF-B dimers toDNA
“B motifs” in the promoter of NF-B-dependent genes (for
review, see Ref. 15). SomeNF-B family members, such as p65/
RelA, must be further phosphorylated (21) (for review, see Ref.
22) to elicit transcriptional activity as well as to afford specific-
ity for subsets of NF-B-dependent genes (21).
As reported hereby, ferrylHb acts as a proinflammatory ago-
nist in EC through activation of the NF-B and mitogen-acti-
vated protein kinase (MAPK) signaling transduction pathways.
Based on this observationwe propose that oxidized cell-freeHb
might contribute to the pathologic outcome of hemolytic
disorders.
EXPERIMENTAL PROCEDURES
Mice—Wild type andTlr2/, 4/, and 9/C57BL/6mice
were maintained at the Instituto Gulbenkian de Cieˆncia under
specific pathogen-free conditions in accordance with guide-
lines from the Animal User and Institutional Ethical Commit-
tees of this institute. Mice were used between 6 and 8 weeks of
age. Tlr2/, 4/, and 9/mice were provided originally by
Dr. Shizuo Akira Research Institute for Microbial Diseases,
Osaka University, Japan.
Cell Culture—Pooled human umbilical vein EC (HUVEC;
Clonetics, Zurich, Switzerland or VEC Technologies Inc.,
Herndon, VA) were cultured on gelatinized plates in EBM-2
(Cambrex BioScience, Wokingham, UK) supplemented with
1% heparin, 0.04% hydrocortisone, 50 g/ml gentamicin sul-
fate/amphotericin, 0.1 ng/ml ascorbic acid, 0.5% human fibro-
blast growth factor B, 0.1% human recombinant vascular endo-
thelial growth factor, 0.1% human recombinant epidermal
growth factor, 0.1% insulin-like growth factor, and 2% heat-
inactivated FCS (Clonetics). HUVEC were passaged 1/3 and
used between passages 4 and 5 2 days post-confluence. Murine
monocytic cell line J774 (ECACC) was cultured in complete
RPMI (10% FCS, 2 mM L-glutamine, 50 units/ml penicillin, and
50 g/ml streptomycin (Invitrogen). Bone marrow-derived
monocyte/macrophages (Mø) were obtained from naive
BALB/c mice by flushing the marrow from femurs and tibias.
The marrow plugs were disrupted into a single cell suspension
and cultured in RPMI (20% FCS, 2mM L-glutamine, 50 units/ml
penicillin, 50 g/ml streptomycin, and 30% supernatant from
L929 cells) for 6 days. On day 6 of culture cells were cultured in
complete RPMI (10% FCS) and used on day 7 in the experimen-
tal assays.
Hb Solutions—Hb at different redox states, i.e. (Fe(II)) Hb,
(Fe(III)) MtHb, and ferrylHb, were prepared as described (3).
Briefly, Hb was isolated from fresh blood drawn from healthy
volunteers using ion-exchange chromatography on a DEAE-
Sepharose CL-6B column (Sigma-Aldrich). MtHb was gener-
ated by incubation (30min, 25 °C) of purifiedHbwith a 1.5-fold
molar excess of K3Fe(CN)6 (Sigma-Aldrich) over heme. Ferryl-
Hb was obtained by incubation (1 h, 37 °C) of Hb with a 10-fold
H2O2 molar excess (Sigma-Aldrich) over heme. After oxida-
tion, both MtHb and ferrylHb were dialyzed (3, 3 h, 100
saline volume, 4 °C) to remove K3Fe(CN)6 andH2O2, separated
into aliquots, snap-frozen in liquid nitrogen, and stored at
80 °C until used. Purity of each Hb preparation was evaluated
by SDS-PAGE followed by silver staining. Hb polymerization
was detected byWestern blot using a chicken anti-human poly-
clonal Hb antibody (ab17542, Abcam, Cambridge, UK). Hb
redox state was assessed by UV-visible spectra recorded on a
Shimadzu UV-3100 spectrophotometer (Shimadzu Scientific
Instruments, Duisburg, Germany) with 1-cm quartz cells
(Hellma, Jena, Germany). Hb dityrosine content was detected
by high performance liquid chromatography (HPLC) with flu-
orescence detection as described (10). Briefly, 100 nmol of Hb
was precipitated with 20% of trichloroacetic acid. After centrif-
ugation (5 min, 1500  g) the pellet was hydrolyzed overnight
(100 °C in 6 mol/liter hydrochloric acid), the liquid was evapo-
rated, and the residuewas dissolved inmethanol and injected to
HPLC using a reverse phase C18 column (4.6 150mm, 5-mm
particle size) and fluorescence detection (Ex 280 nm, Em
410 nm, Merck). The mobile phase consisted of 20% methanol
and 0.2% trifluoroacetic acid in water. The flow rate was 1
ml/min. All reagents were HPLC grade (Merck). Dityrosine
standard was prepared as described (10). Briefly, 10 mmol/liter
L-tyrosine was reacted with 1 mmol/liter H2O2 in the presence
of 1 mol/liter horseradish peroxidase at pH 9.5 for 18 h at
37 °C. The enzyme was removed by ultrafiltration, and the
filtrate was evaporated. The residue was dissolved in ethanol
and chromatographed on a silica thin layer plate (20  20
cm) with an eluent of butanol:acetic acid:water (4:2:1 v/v%).
The fluorescent band with an RF  0.25 was excised and
extracted with methanol and used as a dityrosine standard.
Protein concentration in Hb preparations was determined
spectrophotometrically, as described (4). Endotoxin content
was analyzed by Limulus amebocyte lysate assay (Bio
Whittaker, Inc., Walkersville, MD). To measure H2O2 con-
centration, ferrylHb was filtered (Microcon YM-3 column;
Millipore) (60 min at 14 °C, 21,000  g) to remove proteins
(molecular mass  3 kDa), and the H2O2 in flow-through
was measured using a fluorometric detection kit (Assayde-
sign; Stressgen) in three different preparations of ferrylHb in
triplicate.
Cell Treatments and Reagents—Polymyxin B sulfate (Sigma-
Aldrich) was mixed (15–30 g/ml) with vehicle, ferrylHb (20
M), or lipopolysaccharide (LPS) (100 ng/ml) (30 min, 37 °C).
LPS (Escherichia coli serotype 0127:B8) (Sigma-Aldrich) was
dissolved in phosphate-buffered saline (PBS; Invitrogen). Cat-
alase (Calbiochem, Merck) was incubated with ferrylHb or
vehicle (30min, 37 °C). Hemin (iron protoporphyrin IX) (Fron-
tier Scientific Inc., Logan, UT) was prepared as described (23).
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c-Jun N-terminal kinase (JNK) inhibitor 1 (L-stereoisomer,
Alexis Biochemicals, Lausanne, Switzerland) and p38 MAPK
inhibitor SB203580 (Calbiochem) were dissolved in dimethyl
sulfoxide (DMSO) and added to the culture medium 30 min
before further treatment and left until the end of the experi-
ments. Cytochalasin D and latrunculin B (LatB) (Calbiochem)
were dissolved in DMSO and added to the culture medium 30
min before ferrylHb or LPS and left until the end of the exper-
iments. Jasplakinolide (Calbiochem) was dissolved in DMSO.
Actinomycin D (Sigma-Aldrich) was dissolved in PBS (100
g/ml) and added to culture medium 30 min before the addi-
tion of ferrylHb or LPS and left until the end of the assay. Cyclo-
heximide (Sigma-Aldrich)was dissolved in ethanol (100g/ml)
and added to culture medium at 10 g/ml. Human recombi-
nant TNF (Research and Development, Minneapolis, MN) was
diluted in PBS, 0.1% bovine serum albumin and added to the
culture medium at a final concentration of 50 ng/ml. Pervana-
date (Sigma-Aldrich) was prepared as described (24).
Immunocytochemistry—Confluent HUVEC grown in gelati-
nized glass coverslips were washed in PBS, fixed with 3.7%
paraformaldehyde (20 min, 25 °C), and permeabilized with
0.1% Triton X-100 (Sigma-Aldrich). F-actin and DNA were
stained with TRITC-labeled phalloidin (50 ng/ml, Sigma-Al-
drich) and 4,6-diamidino-2-phenylindole (20 ng/ml, Sigma-
Aldrich), respectively. Cells were analyzed under a fluorescence
microscope (Leica DMRA2, Leica Microsystems, Wetzlar,
Germany). Fluorescence was detected at Ex 535/50 nm and
Em  610/75 nm for TRITC, Ex  480/50 nm and Em 
527/30 nm for ferrylHb, and Ex  360/40 nm and Em 
470/40 nm for 4,6-diamidino-2-phenylindole. Images were
acquired usingMetamorph v4.6r5 software (Universal Imaging
Corp., Downingtown, PA) and analyzed with ImageJ software
(NIH; Bethesda, MD).
siRNA and Transient Transfections—p38 siRNA (sc-29433)
and control siRNA (sc-36869, Santa Cruz Biotechnology),
JNK1, and JNK2 siRNAs (L-003514-00 and L-003505-00,
Dharmacon, Thermo Fisher Scientific) were used at 50 pmol/
well of a 12-well plate. HUVEC were transfected at 75–85%
confluence according to the Invitrogen siRNA protocol for
HUVEC. Briefly, 50 pmol of siRNA were mixed with 4 l of
Oligofectamine (Invitrogen) in 100l of serum free EBM-2 and
incubated for 20 min at 25 °C. During this period the growth
medium from HUVEC was removed, and cells were placed in
400 l of serum free EBM-2. Then 100 l of Oligofectamine/
siRNA transfectionmixturewas added perwell (3 h), and trans-
fection was stopped (250 l of complete EBM-2 containing 6%
FCS). Transfection efficiency (typically 90–100%) was moni-
tored 24 h thereafter, and medium was replaced by complete
EBM-2, 2% FCS. All experiments were carried out 72 h after
siRNA transfections.
Recombinant Adenovirus Transduction and Reporter Assays—
HUVEC at 80–90% confluence were co-transduced with
recombinant adenovirus encoding a NF-B luciferase reporter
(Photinus pyralis luciferase gene under the control of a syn-
thetic promoter containing five binding motifs for NF-B (5-
GGGGACTTTCC-3; NF-B-luc), IB dominant negative
mutant (IB-S32A/S36A; IB DNM)(Vector Biolabs, Phila-
delphia, PA) plus a recombinant adenovirus encoding -galac-
tosidase (LacZ) (a kind gift from Dr. R. Gerard; University of
Texas Southwest Medical Center, Dallas, TX) essentially as
described (14, 25). Experiments were performed 48 h after ade-
novirus transduction. Luciferase expression was quantified
using a single (firefly) luciferase assay system according to the
manufacturer’s instructions (Promega,Madison,WI).-Galac-
tosidase expression was quantified using Galacto-Light Plus
-Galactosidase Reporter Gene Assay System according to the
manufacturer’s instructions (Applied Biosystems, Tropix Inc.,
Bedford, MA). Both luciferase and -galactosidase were meas-
ured using a Microlumat Plus luminometer (LB96V, Berthold,
Bad Wildbad, Germany). Assays were performed in triplicate,
and luciferase values were normalized to -galactosidase. Nor-
malized luciferase activity is shown in arbitrary units.
ELISA—VCAM-1, ICAM-1, and E-selectin protein expres-
sion were measured by cellular ELISA, as described elsewhere
(25). IL-8 was detected using human IL-8 ELISA (BD Bio-
sciences).Murine IL-6 andTNFwere detectedwithmouse IL-6
and TNF ELISA sets, respectively (BD Biosciences).
Oxidative Stress—Intracellular free radical content was meas-
ured by flow cytometry using 5M 5-(and-6)-chloromethyl-2,7-
dichlorofluorescein diacetate acetyl ester (CM-H2DCFDA, Mo-
lecular Probes) as described (26). Cellular thiobarbituric acid
reactive substances were measured according to the manufactur-
er’s instructions (OXI-TEC, Alexis, Nottingham, UK).
Cell Extracts andWestern Blot Analysis—HUVECwere lysed
(20mMTris-HCl, pH 7.5, 150mMNaCl, 1mMNa2EDTA, 1mM
EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM
-glycerophosphate, 1 mM Na3VO4, 1 g/ml leupeptin, and 1
mM phenylmethylsulfonyl fluoride (Sigma-Aldrich)), and pro-
teins were resolved (8–12% SDS-PAGE) and transferred to
polyvinylidene fluoride membranes (Bio-Rad). Membranes
were blotted with antibodies directed against human E-selectin
(sc-14011, Santa Cruz Biotechnology, Santa Cruz, CA),
VCAM-1 (sc-8304, Santa Cruz Biotechnology), ICAM-1
(BBA3, R&D Systems), p65/RelA (sc-372, Santa Cruz Biotech-
nology), phospho-p65-Ser-536 (#3031, Cell Signaling, Danvers,
MA), IB (sc-371, Santa Cruz Biotechnology), phospho-
IB-Ser-32/36 (#9246, Cell Signaling), stress-activated
protein kinase (SAPK)/JNK (#9252, Cell Signaling), phospho-
SAPK/JNK-Thr-183/Tyr-185 (#9251, Cell Signaling), p38
(#9212, Cell Signaling), phospho-p38-Thr-180/Tyr-182
(#9211, Cell Signaling), or anti-IB-phospho-Tyr-42 antibody
(ab24783, Abcam). To ascertain equivalent protein loading,
membranes were stripped and re-probed with a mouse anti-
human -tubulin monoclonal antibody (T9026, Sigma-Aldrich).
Lamin A/C monoclonal antibody (sc-7292, Santa Cruz Bio-
technology) was used as a loading control in nuclear extracts.
Primary antibodies were detected using horseradish peroxi-
dase-conjugated donkey anti-rabbit or goat anti-mouse IgG
secondary antibodies (Pierce). Peroxidase activity was visual-
ized using the SuperSignalWest Pico Chemiluminescent sub-
strate (Pierce). Digital images were obtained using Kodak
Image Station 440CF apparatus (Eastman Kodak Co.). Images
were captured using Adobe Photoshop software, and relative
levels of protein expression were quantified using ImageJ 1.29
software (National Institutes of Health).
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Quantitative Real-time PCR (qRT-PCR)—cDNA was ob-
tained from total RNA isolated from HUVEC or mouse liv-
ers, as described (26, 27). The relative number of mRNA
transcripts was assessed using Light Cycler real-time quan-
titative PCR (Roche Applied Science) using FastStart DNA
SYBRGreen Imix (RocheApplied Science). Transcript number
was calculated using a 2CT method (relative number) or
quantified as an absolute value using standard cDNA plasmids
encoding the same sequences as those amplified by PCR.
Results were normalized to hypoxanthine-guanine-phosphori-
bosyltransferase (Hprt). PCR primers used to quantify human
mRNA transcripts were: 5-GGAGAACCCAGATAGA-
CAG-3 and 5-CCTTCACATAAATAAACCCC-3 for Vcam-1,
5-TCACCTATGGCAACGACTC-3 and 5-GATGGGCAGT-
GGGAAAGTG-3 for Icam-1, 5-ATGTGGAATGATGAGAG-
GTG-3 and 5-AACTGGGATTTGCTGTGTC-3 for E-selec-
tin, and 5-GGCGTCGTGATTAGTGATG-3 and 5-ACTT-
CGTGGGGTCCTTTTC-3 for Hprt. PCR primers used to
quantify murine mRNA transcripts were described elsewhere
(26).
Electrophoretic Mobility Shift Assay—Two days post-con-
fluent HUVEC were exposed to ferrylHb (20 M; 6 h), and
nuclear extracts were prepared as described (14). Electro-
phoretic mobility shift assay was performed with the IgB
probe (sense 5-AGTTGAGGGGACTTTCCCAGGC-3).
The oligonucleotide was labeled by phosphorylation with
[-32P]ATP. Mobility shift was visualized in the form of
autoradiographs.
Viability Assays—HUVEC were treated with ferrylHb (20
M) or cycloheximide plus TNF (8 h), a potent pro-apoptotic
stimulus to EC (27). Cells were washed in PBS and detached
(37 °C, 5 min) with 0.125% trypsin,
0.05% EDTA solution (Invitrogen).
Digestion was stopped (PBS, 10%
FCS), and cells were pelleted (200
g, 4 °C, 3 min), washed (PBS, 3%
FCS), and co-stained with Alexa
Fluor 647-conjugated annexin V
(Molecular Probes, Invitrogen) plus
propidium iodide (0.5 g/ml, P-
4170, Sigma-Aldrich) according to
the manufacturer’s instructions.
Annexin V and propidium iodide
fluorescence were analyzed by flow
cytometry (FACSCalibur, BD Bio-
sciences), and data were analyzed
using FlowJo software (Tree Star,
Inc. Ashland, OR). Alternatively,
viability was assessed by a crystal
violet assay as described (14).
Mouse Peritonitis—C57BL/6 mice
(female, 6–8 weeks of age) were
injected intraperitoneally with 2
mol/kg Hb, MtHb, or ferrylHb in
200 l of apyrogen PBS. Control
mice received PBS only. After 16 h
mice were sacrificed by CO2 expo-
sure, and murine peritoneal leuko-
cytes were harvested by peritoneal lavage using ice-cold apyro-
gen calcium and magnesium-free PBS containing 2% FCS (v/v)
and analyzed by flow cytometry. The total number of cells was
assessed using a fixed number of latex beads (BeckmanCoulter,
Paris, France) and co-acquired with a pre-established volume
of the cellular suspensions. The number of peritoneal poly-
morphonuclear (PMN) cells was evaluated using R-phyco-
erythrin-conjugated rat anti-mouse Ly-6G (Gr1; CD11b)
(BD Biosciences Pharmingen) and biotin anti-mouse neutro-
phils monoclonal antibody (CL8993B, Cedarlane, Hornby,
Ontario, Canada). Cells were co-stained with propidium
iodide (0.5 g/ml) to exclude dead cells. Fluorescence was
measured by flow cytometry, and data were analyzed using
FlowJo software.
Statistical Analysis—Results are presented as the mean 
S.D. or S.E. of independent in vitro or in vivo experiments. Sta-
tistical analysis was performed using unpaired Student’s t test
when the data follow Gaussian distributions, an assumption
tested using the Kolmogorov-Smirnov method. When the data
do not followGaussian distributions, theMann-WhitneyU test
was used instead. Analysis of variance (ANOVA) and the
Tukey-Kramer multiple comparison test were used for com-
parison between values from more than two different groups.
p 0.05 was considered statistically significant.
RESULTS
FerrylHb Induces Actin Rearrangement and Intercellular
Gap Formation in EC—Cell-free ferrous Hb was purified from
human blood of healthy donors and used to generateMtHb and
ferrylHb (4). Relative purity of each Hb preparation was higher
than 95%, as determined by silver staining after SDS/PAGE sep-
FIGURE 1. Characterization of purified Hb, MtHb, and ferrylHb solutions. Purified human Hb, MtHb, and
ferrylHb (20 M each) were resolved by SDS-PAGE and silver stained (A) or transferred to polyvinylidene fluo-
ridemembranes (B), and Hb  chains were detected byWestern blot using an anti-Hb  antibody.M indicates
proteinmolecularmass standards. C, visible spectra of Hb,MtHb, and ferrylHb showing reduced (Fe(II)) ferrous
Hb versus oxidized (Fe(III)) MtHb and ferrylHb. D, dityrosine content in Hb, MtHb, and ferrylHb detected by
HPLC. Results are shown as mean arbitrary units (A.U.) S.D. (n 3 samples). ND indicates not detectable.
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aration (Fig. 1A). Contrary to Hb andMtHb, ferrylHb polymer-
ized, as detected by silver staining (Fig. 1A) and Western blot
(Fig. 1B), which is consistentwith previous reports (28). Ferrous
Hb was in the reduced state, whereas MtHb and ferrylHb were
in the oxidized state, as assessed by spectrophotometry (Fig.
1C). FerrylHb contained dityrosine groups, as detected by
HPLC (Fig. 1D), whereas dityrosine groups were undetectable
in Hb or MtHb (Fig. 1D). Presumably, formation of dityrosine
bonds accounts for ferrylHb polym-
erization (Fig. 1, A and B) (28).
To assess whether cell-free Hb
exerts biologic effects on vascular
EC, post-confluent HUVEC were
exposed in vitro to ferrous Hb,
MtHb, or ferrylHb and analyzed by
fluorescent microscopy. FerrylHb
induced actin polymerization in EC,
as revealed by the formation of fila-
mentous actin (F-actin) bundles, i.e.
stress fibers, in areas juxtaposed to
the deposition of ferrylHb aggre-
gates (Fig. 2, A and B). Neither Hb
nor MtHb led to the formation of
F-actin stress fibers in EC (Fig. 2A).
Furthermore, ferrylHb, but not fer-
rous Hb or MtHb, led to the forma-
tion of intercellular gaps that dis-
rupted the integrity of the EC
monolayer (Fig. 2,A and B). Overlay
of ferrylHb aggregates with F-actin
and intercellular gaps (Fig. 2A) sug-
gests that these events might be
functionally linked; namely, that
aggregation of ferrylHb triggers
actin polymerization and forma-
tion of intercellular gaps. These
effects of ferrylHb were not associ-
ated with EC apoptosis, and/or
necrosis, as assessed by surface
phosphatidylserine expression or
permeability to propidium iodide
(Fig. 2C) and as confirmed by crystal
violet (vital) staining (Fig. 2D).
FerrylHb Induces the Expression
of Proinflammatory Genes in EC—
When exposed to ferrylHb in vitro,
EC up-regulated the expression of
the proinflammatory adhesionmol-
ecules E-selectin (CD62), ICAM-1
(CD54), and VCAM-1 (CD106), as
assessed by cellular ELISA (Fig. 3A)
and Western blot (Fig. 3B). This
effect was dose-dependent in that
increasing concentrations of ferryl-
Hb led to higher levels of expression
of these adhesion molecules (Fig.
3A). When used at the same con-
centrations, neither ferrous Hb nor
MtHb induced the expression of these adhesion molecules in
EC (Fig. 3, A and B).
We compared the proinflammatory effect of ferrylHb to that
of a well established proinflammatory agonist, namely LPS (29).
FerrylHb (20M) and LPS (100 ng/ml) induced similar levels of
E-selectin expression in EC (Fig. 3C), with maximal protein
expression occurring within 4–5 h after ferrylHb or LPS expo-
sure, followed by a decrease to basal levels 16–24 h thereafter
FIGURE 2. FerrylHbdisrupts ECmonolayer integrity.A, confluent HUVECwere exposed (8 h) to Hb,MtHb, or
ferrylHb (20M) or vehicle (control). F-actin (phalloidin-TRITC; red), DNA (4,6-diamidino-2-phenylindole, blue),
and ferrylHb auto fluorescence (green) are shown. B, confluent HUVEC were exposed to ferrylHb or vehicle
(control) and stained as inA.White arrows in A and B indicate F-actin bundles, and dashed yellow circles indicate
intercellular gaps; images are 400, representative of three independent experiments, each in triplicate.
C, confluent HUVEC were untreated (Control) or exposed (8 h) to ferrylHb (20 M) or cycloheximide (CHX; 10
g/ml) plus TNF (50 ng/ml). Viability was assessed by annexin V and propidium iodide (PI) staining and mon-
itored by flow cytometry. D, HUVEC were treated as in C, and viability was assessed by crystal violet staining.
Data show the mean  S.D. (n  3) from 1 of 3 independent experiments. p value was calculated using
unpaired Student’s t test.
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(Fig. 3C). Induction of ICAM-1 and
VCAM-1 expression by ferrylHb
was significantly lower, as com-
pared with LPS (Fig. 3C), even
though the kinetic of expression of
these adhesion molecules was quite
similar (Fig. 3C).
When exposed to ferrylHb, Mø
did not induce the expression of
proinflammatory genes as assessed
for TNF (Fig. 4, A and B) and IL-6
(Fig. 4, C and D), two proinflamma-
tory cytokines that play an essen-
tial role in the effector phase of
inflammatory responses. Similar
results where obtained using ei-
ther primary Mø (bone marrow-
derived) (Fig. 4, A and C) or the
monocytic cell line J774 (Fig. 4, B
andD). This suggests that the proin-
flammatory effect of ferrylHb is
somehow restricted to EC.
We tested whether ferrylHb in-
duces the expression of proinflam-
matory genes other than those
encoding for adhesion molecules.
Contrary to LPS, however, ferrylHb
failed to induce the expression/se-
cretion of the chemokine IL-8 in EC
(Fig. 5A). This suggests that ferryl-
Hb and LPS induce the expression of different subsets of proin-
flammatory genes in EC, presumably acting via distinct
mechanisms.
The Proinflammatory Effect of FerrylHb Is Not because of
Putative Contaminants—Cell-free Hb can synergize with LPS
(30, 31), raising the possibility that the proinflammatory effect
of ferrylHb might be because of a putative contamination by
LPS, i.e. endotoxin. This possibility was discarded based on the
following set of observations. First, the endotoxin content of
purified ferrylHb was 2 pg/ml, which fails to induce the
expression of proinflammatory genes in EC (32). Second, poly-
myxin B, a molecule that binds to and inactivates endotoxin
(33), did not suppress the proinflammatory effect of ferrylHb
but did so for LPS, as assessed by VCAM-1 expression (Fig. 5B).
Third, heat denaturation suppressed the proinflammatory
effect of ferrylHb but did not interfere with that of LPS, as
assessed by VCAM-1 expression (Fig. 5B). These observations
support the notion that ferrylHb induces the expression of
proinflammatory genes in EC via a mechanism that is not
attributable to a putative endotoxin contamination.
We tested whether the proinflammatory effects of ferrylHb
could be attributed to heme release from ferrylHb, which could
act as a proinflammatory agonist in EC (34). However, free
heme failed to induce the expression of E-selectin, ICAM-1, or
VCAM-1 in EC (Fig. 5C), suggesting that the proinflammatory
effect of ferrylHb is not attributable to heme release from its
globin chains. In keeping with this notion, MtHb, which can
release its heme groups as does ferrylHb (3, 34), fails to induce
FIGURE 3. FerrylHb induces the expression of adhesionmolecules in EC.A, confluent HUVECwere exposed
(8 h) to increasing concentration of Hb,MtHb, ferrylHb, or vehicle, and E-selectin, VCAM-1, and ICAM-1 protein
expressionwas detected by cellular ELISA. B, confluent HUVECwere exposed (8 h) to Hb, MtHb, or ferrylHb (20
M), andE-selectin, VCAM-1, and ICAM-1protein expressionwasdetected inwhole cell lysatesbyWesternblot.
Immunoblots are representative of three independent experiments. C, confluent HUVEC were exposed to
ferrylHb (20 M) or LPS (100 ng/ml), and E-selectin, VCAM-1, and ICAM-1 protein expression was detected by
cellular ELISA. Results inA and C are themean S.D. (n 3) from1of 3 independent experiments. ANOVA and
the Tukey-Kramer multiple comparison test were used to calculate p values in A. p values in Cwere calculated
by using unpaired Student’s t test.
FIGURE 4. FerrylHb does not evoke a proinflammatory response in Mø.
A, bonemarrow-derivedMøwere left untreated (Cont) or exposed to LPS (10
ng/ml) or to ferrylHb. TNF concentration in cell culture supernatant was
measured by ELISA. B, the monocytic J774 cell line was left untreated or
exposed to LPS (100 ng/ml; 24 h) or ferrylHb (20M; 24 h). TNF concentration
was measured as in A. Bone marrow-derived Mø (C) or monocytic J774 cells
(D) were treated as in A and B, respectively, and IL-6 concentrationwasmeas-
ured in cell culture supernatant by ELISA. Results are shown as the mean 
S.D. (n 3) from one representative experiment of three. p values were cal-
culated using ANOVA and the Tukey-Kramer multiple comparison test.
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the expression of E-selectin, ICAM-1, or VCAM-1 in EC (Fig. 3,
A and B).
Because ferrylHb is generated through oxidation of ferrous
Hb by H2O2, we asked whether the proinflammatory effect of
ferrylHb is because of trace amounts of H2O2 that could syner-
gize with ferrylHb to support this effect.We have excluded this
possibility based on the observation that (i) purified ferrylHb
contains less than 1 nM H2O2, (ii) preincubation of ferrylHb
with catalase, an enzyme that converts H2O2 into H2O, did not
suppress the proinflammatory effect of ferrylHb, as assessed by
VCAM-1 expression (Fig. 5D), and (iii) H2O2 (100–500 M)
failed to induce the expression of VCAM-1 in EC (Fig. 5E).
FerrylHb induced a mild accumulation of free radicals in
EC, as detected by flow cytometry using the free radical
probe 5-(and-6)-chloromethyl-2,7-dichlorofluorescein diac-
etate acetyl ester (supplemental Fig. 1A) as well as by the pro-
duction of thiobarbituric acid reactive substances, a marker of
lipid peroxidation (supplemental
Fig. 1B). However, the proinflam-
matory effect of ferrylHb was not
inhibited by the antioxidantsN-ace-
tylcysteine or butylated hydroxyani-
sole (tert-butyl-4-hydroxyanisole)
(supplemental Fig. 1C–E), suggest-
ing that accumulation of free radi-
cals is not a major mechanism via
which ferrylHb exerts its proinflam-
matory effects in EC.
The Proinflammatory Effect of
FerrylHb Is Regulated Transcrip-
tionally—Upon exposure to ferryl-
Hb, EC up-regulated the expression
of mRNAs encoding E-selectin,
Icam-1, and Vcam-1, as assessed by
qRT-PCR (Fig. 6A). Expression of
these mRNAs increased from 2 to
5 h after ferrylHb exposure, de-
creasing thereafter to regain basal
levels (data not shown). FerrylHb
did not modulate the expression of
mRNA encoding Hprt. Moreover,
neither ferrous Hb nor MtHb
induced the expression of E-selec-
tin, Icam-1, or Vcam-1 mRNAs, as
compared with untreated EC (Fig.
6A). Inhibition of gene transcrip-
tion by actinomycin D suppressed
the up-regulation of mRNAs
encoding E-selectin, Icam-1, and
Vcam-1 in response to ferrylHb
(Fig. 6B). Taken together, these
data suggest that ferrylHb induces
the expression of these mRNAs via
a mechanism regulated at the
transcriptional level, i.e. inhibited
by actinomycin D.
We asked whether ferrylHb in-
duces in vivo the expression of
adhesion molecules associated with EC activation. When
administered into naïve mice (intravenous), ferrylHb induced
the expression of mRNA encoding E-selectin, Icam-1, and
Vcam-1, as assessed in the liver by qRT-PCR (Fig. 6C). Because
expression of some of these adhesion molecules, i.e. E-selectin,
is restricted to vascular EC, this observation supports the
notion that in a similarmanner towhat occurs in vitro, ferrylHb
can induce in vivo the expression of proinflammatory genes
in EC.
The Proinflammatory Effect of FerrylHbActs via Activation of
the NF-B Family of Transcription Factors—Most of the proin-
flammatory genes expressed during EC activation are regulated
at the transcriptional level via activation of the NF-B family of
transcription factors (13, 14). In keeping with this notion,
ferrylHb led to sustained phosphorylation and partial degrada-
tion of the NF-B inhibitormolecule IB, as assessed in EC by
Western blot (Fig. 7A). FerrylHb also induced phosphorylation
FIGURE 5. Theproinflammatory effect of ferrylHb is not attributable to putative contaminants.A, conflu-
ent HUVEC were exposed (8 h) to ferrylHb (20 M) or LPS (100 ng/ml), and IL-8 concentration in culture
supernatantwasmeasuredby ELISA. Results shownare themeanvalues S.D. (n3) from1of 4 independent
experiments. B, HUVECwere treated as in A, andwhen indicated (	) ferrylHb and LPSwhere preincubated (30
min) with polymixin B (polyB) or subjected to heat inactivation (80 °C; 20min). VCAM-1 protein expressionwas
measured by cellular ELISA. Results shown are the mean values  S.D. (n  3) from 1 of 4 independent
experiments.n.s., not significant.C, confluentHUVECwere exposed to equivalentmolar amounts of ferrylHbor
heme, and E-selectin, ICAM-1, and VCAM-1 protein expression was detected by cellular ELISA. Results shown
are themeanvalues S.D. (n3) from1of 3 independent experiments.D, confluentHUVECwere treatedwith
vehicle alone or vehicle exposed to catalase (37 °C; 30min) (Control) or to ferrylHb (8 h; 20M) alone or ferrylHb
exposed to catalase. VCAM-1 protein expression was measured by cellular ELISA. Results are shown as the
mean S.D. (n 3) from 1 of 3 independent experiments. E, confluent HUVEC were left untreated (Cont) or
exposed (8 h) to ferrylHb (20 M) or to H2O2, and VCAM-1 expression was measured by cellular ELISA. Results
shown are themean values S.D. (n 3) from 1 of 3 independent experiments. p values shown in A, B,D, and
Ewere calculated using ANOVA and the Tukey-Kramermultiple comparison test. p values in Cwere calculated
by using unpaired Student’s t test.
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of p65/RelA, i.e. Ser-536 (Fig. 7B), a NF-B familymember crit-
ically involved in the regulation of the expression of proinflam-
matory genes associated with EC activation (14). FerrylHb led
to p65/RelA nuclear translocation (Fig. 7C) and NF-B binding
to DNA B binding motifs (Fig. 7D), as assessed by Western
blot and electrophoretic mobility shift assay, respectively.
FerrylHb induced by 4–16-fold NF-B transcriptional activity in
EC, as assessed using a synthetic NF-B-luciferase reporter
(Fig. 7E). This effectwas dose-dependent in that higher concen-
trations of ferrylHb led to increased NF-B activity (Fig. 7E).
The proinflammatory effect of ferrylHb was suppressed when
EC were transduced with a recom-
binant adenovirus encoding a dom-
inant negativemutant form of IB,
as assessed by VCAM-1 expression
(Fig. 7, F and G). Taken together,
these observations reveal that the
proinflammatory effect of ferrylHb
occurs through a mechanism de-
pendent on the activation of the
transcription factor NF-B.
The Proinflammatory Effect of
FerrylHb Is Dependent on Actin
Polymerization—Given that ferrylHb
induces actin polymerization (Fig. 2,
A and B), we asked whether this
effect is functionally linked to its
proinflammatory effect, i.e. induc-
tion of adhesion molecule expres-
sion (Fig. 3). Pharmacological inhi-
bition of actin polymerization by
cytochalasin D (35) suppressed the
proinflammatory effect of ferrylHb,
as assessed by VCAM-1 expression
in EC (Fig. 8, A and B). The effect
of cytochalasin D was dose-depend-
ent, with higher concentrations
reducing further ferrylHb-driven
VCAM-1 expression in EC (Fig. 8A).
Moreover, the effect of cytochalasin
Dwas specific in that cytochalasinD
failed to inhibit the proinflamma-
tory effect of LPS, as assessed by
VCAM-1 expression (Fig. 8A). Sim-
ilar results were obtained using
LatB, a compound that alters the
actin-monomer subunit interface
to prevent its polymerization (36)
(Fig. 8, A and B). The effect of LatB
was also dose-dependent, with
higher concentrations increasing
its inhibitory effect of ferrylHb-
driven VCAM-1 expression (Fig.
8A). The effect of LatB was specific
in that it did not inhibit LPS-driven
VCAM-1 expression (Fig. 8A). We
assessed whether actin polymeriza-
tion is sufficient per se to induce the
expression of proinflammatory genes associated with EC acti-
vation. VCAM-1 expression was induced in EC exposed to jas-
plakinolide, an actin-stabilizing toxin that polymerizes actin
(37) (Fig. 8, C and D).
Having established that the proinflammatory effect of ferryl-
Hb is dependent on actin polymerization (Fig. 8,A–D) aswell as
onNF-B activation (Fig. 7), we askedwhether these two events
are functionally linked. Both cytochalasin D and LatB sup-
pressed NF-B activation by ferrylHb, as assessed in EC trans-
duced with a synthetic NF-B luciferase reporter (Fig. 8E). This
suggests that actin polymerization acts “upstream” of NF-B in
FIGURE6.FerrylHb induces the transcriptionofproinflammatorygenes.A, confluentHUVECwereexposed
(4 h) to Hb, MtHb, ferrylHb (20 M), or vehicle (Cont) and E-selectin, Icam-1, and Vcam-1mRNA expression was
quantified by qRT-PCR. B, confluent HUVEC were pretreated or not with actinomycin D (5 g/ml; 30 min) and
exposed (4 h) to ferrylHb (20M) or vehicle (Cont). E-selectin, Icam-1, and Vcam-1mRNA expression was quan-
tifiedbyqRT-PCR. Values arenormalized to theexpressionofmRNAencoding thehousekeepinggeneHprt and
are shown as a mean fold-induction versus control S.D. (n 3), from 1 of 3 experiments. Act.D, actinomycin
D. C, C57BL/6mice were either not treated (NT) or received vehicle (intravenous PBS) or ferrylHb (intravenous;
8mol/kg in 200l of apyrogenic PBS). E-selectin, Icam-1, and Vcam-1mRNA expression was quantified in the
liver by qRT-PCR. Values are shown as the number of E-selectin, Icam-1, or Vcam-1 perHprtmRNAmolecules
S.D. (n  4 per group) in 1 of 2 experiments. p values were calculated using ANOVA and the Tukey-Kramer
multiple comparison test. NT, not treated.
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the signaling transduction pathway via which ferrylHb
induces the expression of proinflammatory genes in EC.
Moreover, actin polymerization by jasplakinolide induced a
mild but significant activation of NF-B in EC, as assessed
using a NF-B luciferase reporter (Fig. 8F). Taken together,
these observations reveal that ferrylHb exerts proinflamma-
tory effects in EC via a mechanism dependent on actin
polymerization.
The Proinflammatory Effect of FerrylHb Is Dependent on the
Activation of the p38 MAPK and JNK Signaling Transduction
Pathways—FerrylHb induced the activation of the p38 MAPK
signal transduction pathway in EC, first detected within 2–4
h after ferrylHb exposure and
increasing thereafter until 16 h, the
last time point analyzed (Fig. 9A).
Pharmacological inhibition of p38
MAPK activation by the pyridine
imidazole SB203580 suppressed the
proinflammatory effect of ferrylHb,
i.e. 
90% reduction in VCAM-1
protein expression (Fig. 9B). Ferryl-
Hb also induced the activation of
the JNK signal transduction path-
way in EC, first detected 1 h after
ferrylHb exposure and increasing
thereafter until 16 h, the last time
point analyzed (Fig. 9C). Pharmaco-
logical inhibition of JNK activation
by L-stereoisomer (JNKi-1) reduced
by 
50% the proinflammatory
effect of ferrylHb, as assessed by
VCAM-1 expression (Fig. 9D).
The involvement of the p38 and
JNK signal transduction pathways
in the proinflammatory effect of
ferrylHb was confirmed by targeting
specifically these kinases using
siRNA. Inhibition of p38 MAPK
expression suppressed the proin-
flammatory effect of ferrylHb, i.e.
95% reduction in VCAM-1 pro-
tein expression, as compared with
control siRNA (Fig. 9E). Targeting
JNK1 and JNK2 expression with
siRNAs also inhibited the proin-
flammatory effect of ferrylHb, i.e.

40% decrease in VCAM-1 protein
expression, as compared with con-
trol siRNA (Fig. 9F). These observa-
tions reveal that activation of p38
MAPK and JNK is required to sus-
tain the proinflammatory effect of
ferrylHb in EC. It should be noted
that the antibody used to detect
JNK1/2 in HUVEC appears to
detect predominantly the JNK2 iso-
form (Fig. 9, C and F). However, an
anti-JNK1 siRNA, which does not
suppress JNK2 expression (Fig. 9F), appears to be as efficient as
an anti-JNK2 siRNA in inhibiting the proinflammatory effect of
ferrylHb in EC, thus suggesting that JNK1 and JNK2 are both
required to sustain the proinflammatory effect of ferrylHb. Of
notice aswell, the transfection reagents, i.e.Oligofectamine and
siRNAs, induced per se the expression of VCAM-1 in EC (Fig. 9,
E and F). This effect was not related to siRNA specificity, it was
observed using Oligofectamine alone (Fig. 9E) or Oligo-
fectamine plus nonspecific siRNA (Fig. 9, E and F).
We then asked whether p38 MAPK or JNK activation is
required to support NF-B activation and/or the expression of
proinflammatory genes in response to ferrylHb. Pharmacolog-
FIGURE 7. FerrylHb activates NF-B in EC. A and B, confluent HUVEC were exposed to ferrylHb (20 M) for
increasingperiodsof timeoruntreated (NT), andproteinsweredetected inwhole-cell extracts byWesternblot.
C, confluent HUVEC were exposed (6 h) to ferrylHb (20 M) or not (), and p65/RelA was detected in nuclear
extracts byWesternblot. LaminA/C and-tubulinwere used as nuclear and cytoplasmicmarkers, respectively.
Immunoblots are representative of three independent experiments. D, confluent HUVEC were treated as in C,
and nuclear NF-B binding to DNA B probe was detected by electrophoretic mobility shift assay. Arrows I, II,
and III indicate specific binding to the DNA B probe. The asterisk indicates competition (20) with non-
radiolabeled B DNA probe. ns, not specific. N.Ext, Nuclear extract. E, confluent HUVEC co-transduced with
NF-B-Luc and CMV-LacZ recombinant adenoviruswere exposed (8 h) to ferrylHb or not (Cont). Luciferasewas
normalized to -galactosidase units and results are shown as the mean fold-induction versus control (not
exposed to ferrylHb)S.D. (n3), from1of 3 independent experiments.pvalueswere calculatedwithANOVA
and the Tukey-Kramermultiple comparison test. F, confluent HUVECwere co-transduced or not (NT) with LacZ
or IB(DNM) recombinant adenovirus and exposed (8 h) to ferrylHb (20 M) or not (Control). Proteins were
detected in whole cell lysates by Western blotting. Immunoblots are representative of three independent
experiments. G, confluent HUVECwere treated as in F, and VCAM-1 was detected by cellular ELISA. Results are
the mean values  S.D. (n  3) from 1 of 4 independent experiments. p value was calculated with unpaired
Student’s t test.
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ical inhibition of p38 MAPK by SB203580 failed to inhibit
NF-B activation in EC (Fig. 9G) under the same experimental
conditions leading to VCAM-1 inhibition (Fig. 9B). This sug-
gests that p38 MAPK and NF-B activation act independently
of each other to promote the transcription/expression of proin-
flammatory genes in response to ferrylHb. Pharmacological
inhibition of JNK by JNKi-1 inhibited by 40% the activation of
NF-B by ferrylHb (Fig. 9H). This suggests that ferrylHb
induces the activation of NF-B via a mechanism involving the
activation of JNK.
FerrylHb Acts as a Proinflammatory Agonist in Vivo—We
asked whether ferrylHb exerts proinflammatory effects in vivo
such as when administered into the
peritoneal cavity of naïve C57BL/6
mice, a well established experimen-
tal model of “sterile” inflammation
(38, 39). FerrylHb induced a robust
inflammatory response, revealed by
an average 19-fold increase in the
number of peritoneal Ly6G	7/4	
PMN cells, as compared with vehi-
cle-treated controls (Fig. 10, A and
B). This effect was not observed
using equimolar amounts of Hb or
MtHb (Fig. 10, A and B), which is in
keeping with the observation that
Hb or MtHb do not exert proin-
flammatory effects in EC in vitro
(Fig. 3). To test whether the proin-
flammatory effect of ferrylHb is
because of LPS, i.e. endotoxin, we
assessedwhether this effect is lost in
mice lacking the LPS receptor Toll-
like receptor 4 (TLR4), i.e. C57BL/
6.Tlr4/mice (40). FerrylHb led to
similar levels of PMNcell influx into
the peritoneal cavity ofTlr4/ ver-
sus wild type Tlr4	/	mice (Fig. 10,
C and D), which discards the possi-
bility that the proinflammatory
effect of ferrylHb is because of a
putative endotoxin contamination
and, thus, supports the notion that
ferrylHb is a bona fide proinflam-
matory agonist.
DISCUSSION
Several pathological conditions
are associated with varying levels of
hemolysis and, therefore, withmore
or less extensive accumulation of
cell-free Hb in plasma (for review,
see Ref. 2). Under homeostasis, the
deleterious effects of cell-free Hb
are controlled by haptoglobin (41), a
plasma protein that binds cell-free
Hb with high affinity (42), promot-
ing its recognition by the CD163
receptor expressed by hemophagocyticMø (43) (for review, see
Ref. 44). Hb degradation inMø induces the expression of heme
oxygenase-1 (43), which catabolizes the heme prosthetic
groups of Hb into CO, iron, and biliverdin (45) and then con-
verted, by biliverdin reductase, into the antioxidant bilirubin
(46). The cytoprotective and antioxidant effects associatedwith
heme catabolism by heme oxygenase-1 (for review, see Ref. 47,
48) are key in maintaining the homeostatic control of cell-free
Hb, as revealed in Hmox1-deficient mice (49) as well as in the
one case of HMOX1 deficiency reported in humans (50). This
notion is further supported by the observation that the main
clinical feature of human HMOX1 deficiency is severe chronic
FIGURE 8. The proinflammatory effect of ferrylHb is dependent on actin polymerization. A, confluent
HUVECwere exposed to cytochalasinD (Cyto.D; 0.25–1M; 30min), LatB (0.25–1M; 30min), or vehicle () and
not further treated () or exposed (8h) to ferrylHb (20M)or LPS (100ng/ml). VCAM-1expressionwasdetected
by cellular ELISA.B, confluentHUVECwere treatedwith cytochalasinD (0.5M; 30min;	), latrunculin B (0.5M;
30 min;	) or vehicle () and not further treated (Control) or exposed (8 h) to ferrylHb (20 M). Proteins were
detected inwhole cell lysates byWestern blotting. C andD, confluent HUVECwere exposed (8 h) to jasplakino-
lide (Jas) or to vehicle (C), and VCAM-1 protein expression was measured by cellular ELISA (C) or by Western
blotting (D). E, confluent HUVEC were transduced (48 h) with NF-B-Luc and LacZ recombinant adenovirus,
treated with cytochalasin D (0.5 M; 30 min;	), latrunculin B (0.5 M; 30 min;	), or vehicle (), and then not
further treated () or exposed (8h) to ferrylHb (20M). Luciferasewasnormalized to-galactosidaseunits, and
values are represented as mean fold-induction versus control non-treated cells  S.D. (n  3) from 1 of 3
independent experiments. p values were calculated with the unpaired Student’s t test. F, confluent HUVEC
were transducedas in Eandeithernot treated, treated (8h)with jasplakinolide, or vehicle (C), and the rest of the
procedure was done as in E. Results in A, C, E, and F are themean values S.D. (n 3) from 1 of 3 independent
experiments. p valueswere calculatedwith ANOVA and the Tukey-Kramermultiple comparison test. Immuno-
blots in B and D are representative of three independent experiments.
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intravascular hemolysis associated with oxidation of cell-free
Hb (51) and the development ofmicro- andmacroangiopathies
(52).
Under inflammatory conditions, cell-free Hb can react with
reactive oxygen species, such as H2O2 produced by activated
PMNcells orMø (3, 53). This reaction can generate, in addition
to MtHb, an unstable oxidized form of Hb, i.e. ferrylHb (4–6),
detected in humans under physio-
logic (54) and pathophysiologic
conditions (55–57). Contrary to
other forms of Hb, ferrylHb under-
goes intermolecular cross-linking of
its globin chains via oxidation of
tyrosine residues that can formdity-
rosine covalent bonds (Fig. 1). The
resulting ferrylHb multimers have
reduced affinity toward haptoglobin
(9, 28), bypassing the homeostatic
control of cell-free Hb exerted by
the haptoglobin-CD163-heme oxy-
genase-1 scavenging pathway.
We hypothesized that the oxi-
dized forms of Hb might exert
proinflammatory effects in vascular
EC. As demonstrated hereby, ferryl-
Hb but not MtHb can exert proin-
flammatory effects in EC that are
not associated with its previously
established cytotoxic effects in EC
(11) (Fig. 2, C and D).
MtHbhas been suggested to exert
proinflammatory effects in EC (58).
However, our data suggests that this
proinflammatory effect is attributa-
ble to a contamination of commer-
cially available MtHb by endotoxin
(58), a commonartifact in these type
of studies (59). We found that com-
mercially available MtHb (58) can
contain up to 40 ng of endotox-
in/mg of protein (data not shown),
which is more than 2000 times the
amount of endotoxin in the Hb
preparations used in our study.
Moreover, the proinflammatory
effect of MtHb (58) is ablated using
endotoxin-free MtHb (Fig. 3) and
cells lacking the endotoxin receptor,
i.e. TLR4 also fail to respond to
commercially available MtHb (sup-
plemental Fig. 2). Together, these
observations argue that the previ-
ously proinflammatory effects of
MtHb (58) ismost probably because
of an endotoxin contamination
rather than to MtHb itself.
When exposed in vitro to ferryl-
Hb (5–20 M), EC rearrange their
actin cytoskeleton, as revealed by the formation of F-actin
stress fibers/bundles (Fig. 2, A and B). This is associated with
the formation of intercellular gaps disrupting the integrity of
the EC monolayer (Fig. 2, A and B), a highly deleterious event
that promotes unfettered extravascular leakage and exposes the
pro-coagulant sub-endothelial matrix to the clotting cascade
(60).
FIGURE 9. The proinflammatory effect of ferrylHb is dependent on the activation of the p38 MAPK and
JNK. A, confluent HUVECwere either untreated (NT) or exposed (8 h) to ferrylHb (20M) for increasing periods
of time, and proteins were detected in whole cell lysates by Western blotting. B, confluent HUVEC were
exposed to the p38MAPK inhibitor SB203580 or to vehicle and not further treated (Control) or exposed (8 h) to
ferrylHb (20M). VCAM-1was detected by cellular ELISA. C, confluent HUVECwere treated as inA, and proteins
were detected in cell lysates byWestern blot.D, confluent HUVECwere pretreatedwith JNKi-1 or with vehicle,
and the rest of the procedure was done as in B. Results in B and D are themean values S.D. (n 3) from 1 of
3 independent experiments.p valueswere calculatedwithANOVAand the Tukey-Kramermultiple comparison
test. E, confluent HUVECwere not transfected () or transfectedwith control (ctr) or anti-p38MAPK siRNA and
exposed (8 h) to ferrylHb (20 M) or to vehicle (NT). Proteins were detected as in A. Control cells () received
transfection reagent Oligofectamine. F, confluent HUVECwere not transfected () or transfected with control
(ctr) or anti-JNK1 or -JNK2 siRNA. The rest of the procedure was the same as in E. Immunoblots in A, C, E, and F
are representative of three independent experiments.G andH, confluent HUVECwere transducedwithNF-B-
Luc and LacZ recombinant adenovirus, treatedwith SB203580 (G), JNKi-1 (H), or vehicle andnot further treated
(Control) or exposed (8 h) to ferrylHb (20M). Luciferasewas normalized to-galactosidase units and shown as
the mean fold-induction versus control S.D. (n 3) from 1 of 3 independent experiments. p values in G and
Hwere calculated with the unpaired Student’s t test.
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When exposed in vitro to ferrylHb, ECup-regulate the rate of
transcription of several proinflammatory genes, i.e. E-selectin,
Icam-1, andVcam-1 (Figs. 3 and 6,A and B) through activation
of the NF-B family of transcription factors (Fig. 7) via a mech-
anism that is not totally clear. FerrylHb causes a modest and
delayed (i.e. 4–8 h after stimulation) phosphorylation of IB
at Ser-32/36 (Fig. 7A), leading to a similarlymodest and delayed
degradation of IB (Fig. 7A) that does not seem to account for
the observed induction of NF-B nuclear translocation (Fig. 7,
C andD) and activity (Fig. 7E). One possible explanation for this
would be that ferrylHb triggers IB phosphorylation at Tyr-
42, leading to NF-B activation without the need for IB deg-
radation (61). However, ferrylHb leads to a very modest IB
Tyr-42 phosphorylation in EC (supplemental Fig. 3), which dis-
cards this possibility. An alternative explanation might be that
IB phosphorylation in response to ferrylHb would occur at a
cluster of C-terminal phosphoacceptors, leading to robust acti-
vation of NF-B despite the modest degradation of IB, as
observed in response to UV radiation (62). This atypical path-
way of NF-B activation is mediated by the stress-responsive
casein kinase II ( and ) (62). Whether ferrylHb induces the
activation of NF-B in EC through the activation of casein
kinase II remains to be tested.
In addition, from NF-B, ferrylHb activates other signal
transduction pathways that are required to sustain its proin-
flammatory effect (Fig. 9). This is the case for p38MAPK,which
promotes the proinflammatory effect of ferrylHb (Fig. 9, A, B,
and E) withoutmodulatingNF-B activity (Fig. 9G) via amech-
anism that remains to be established. Activation of JNK by
ferrylHb is part of another signal transduction pathway
involved in the proinflammatory effect of ferrylHb (Fig. 9,C,D,
and F). Contrary to p38 MAPK, however, JNK activation mod-
ulates NF-B activity (Fig. 9H) via amechanism that remains to
be established.
Inhibition of actin polymerization by cytochalasin D signifi-
cantly decreases (
40%) p38 MAPK activation in response to
ferrylHb (supplemental Fig. 4A), suggesting that actin polym-
erization acts upstreamof p38MAPK in the signal transduction
pathway induced by ferrylHb and leading to the expression of
adhesion molecules in EC. On the other hand, cytochalasin D
enhanced JNKactivation in response to ferrylHb (supplemental
Fig. 4B), suggesting that actin polymerization in response to
ferrylHb has opposite effects on the p38MAPK and JNK signal
transduction pathways, activating p38 MAPK while inhibiting
JNK activation. The mechanisms underlying these effects
remain to be established.
The proinflammatory effect of ferrylHb can be dissociated
from its pro-oxidant activity (supplemental Fig. 1) and as such
is refractory to antioxidants such as catalase (Fig. 5D), N-ace-
tylcysteine or butylated hydroxyanisole (tert-butyl-4-hy-
droxyanisole) (supplemental Fig. 1, C–E). Furthermore, this
proinflammatory effect is not attributable either to heme
release from ferrylHb (Fig. 5C), to generation of free radicals, i.e.
H2O2 (data not shown), or putative contaminants such as endo-
toxin (Figs. 5B and 10, C and D) or H2O2 (Fig. 5E).
Activation of NF-B and expression of proinflammatory
genes in response to ferrylHb is dependent on actin polymeri-
zation (Fig. 8). This would suggest that ferrylHb might require
phagocytosis, a process regulated through actin polymeriza-
tion, to exert its proinflammatory effect in EC. This notion is
consistent with the observation that other endogenous proin-
flammatory agonists such as uric acid crystals require phagocy-
tosis to act in a proinflammatory manner (38). Alternatively,
however, ferrylHb might exert proinflammatory effects in EC
FIGURE 10. FerrylHb is proinflammatory in vivo. Naïve C57BL/6 mice received a bolus administration (intraperitoneal) of Hb, MtHb, or ferrylHb or PBS.
A, representative dot blots of peritoneal Ly-6G	 7/4	 PMN cells 16 h after stimulus. B, mean number of Ly-6G	 7/4	 PMN cells S.E. (PBS, n 11; Hb, n 5;
MtHb, n 9; ferrylHb, n 15) plotted from three independent experiments. ns, not significant.C, representative dot blots of peritoneal Ly-6G	 7/4	 PMNcells
in C57BL/6.Tlr4	/	 versus C57BL/6.Tlr4/ mice 16 h after ferrylHb administration. D, mean number of Ly-6G	 7/4	 PMN cells  S.E (Tlr4	/	/PBS, n  11;
Tlr4	/	/ferrylHb,n 12; Tlr4//PBS and Tlr4//ferrylHb,n 9), plotted from three independent experiments. p valueswere calculatedwithANOVAand the
Tukey-Kramer multiple comparison test.
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through activation of a signal transduction pathway involving
actin polymerization (Fig. 8, E and F), as is the case for throm-
bin, an endogenous proinflammatory agonist that induces the
expression of adhesion molecules in EC through the activation
of NF-B by a signal transduction pathway involving actin
polymerization (3, 53). These two possibilities are not mutually
exclusive.
Given that ferrous Hb and MtHb do not mimic the proin-
flammatory effects of ferrylHb (Figs. 2A, 3,A and B, 6A, and 10,
A and B), it is likely that ferrylHb undergoes specific “confor-
mational”modifications to become proinflammatory (63). This
notion is consistentwith the observation that, contrary toHbor
MtHb, ferrylHb forms multimeric hydrophobic aggregates
(Figs. 1,A and B and 2A). Hydrophobicity has been proposed to
act as a common molecular denominator recognized by innate
germ line-encoded pattern recognition receptors (59). Engage-
ment of pattern recognition receptors elicits inflammatory
responses through activation of signal transduction pathways
that include those activated by ferrylHb in EC, e.g.NF-B, JNK,
and p38 MAPK (64).
These observations suggest that, in a similar manner to
other endogenous proinflammatory agonists, e.g. uric acid
(35, 36, 52) or peptide amyloid- (65), ferrylHb might act as
an endogenous proinflammatory ligand recognized by
innate pattern recognition receptors. One possibility would
be that ferrylHb is recognized by NOD-like receptors that
form multimeric cytoplasmic complexes, i.e. inflamma-
somes, linking recognition of proinflammatory ligands to
proteolytic activation of proinflammatory cytokines, e.g.
IL-1 (for review, see Ref. 66). This hypothesis is consistent
with the observation that the proinflammatory effect of
ferrylHb is exerted in vivo via a mechanism involving the
IL-1/IL-1R signal transduction pathway (data not shown).
Contrary to other proinflammatory agonists, however,
ferrylHb does not seem to elicit proinflammatory effects in
innate immune cells such as Mø (Fig. 4) or dendritic cells
(data not shown), as tested in vitro. This suggests that ferryl-
Hb targets specifically EC via a mechanism that has not been
established but that could rely on the expression of a specific
receptor recognizing ferrylHb. The observation that ferryl-
Hb, but not ferrous Hb or MtHb, can elicit inflammatory
responses in mice (Figs. 6C and 10, A and B) supports the
notion that ferrylHb might act as an endogenous proinflam-
matory agonist in vivo.
Although we have not demonstrated unequivocally that the
proinflammatory effect of ferrylHb in vivo acts via the same
mechanisms that are operative in vitro, this is likely to be the
case, as ferrylHb can induce in vivo the expression of adhesion
molecules associated with EC activation (Fig. 6C), which are
required to sustain recruitment of PMN cells (67) as triggered
by ferrylHb in vivo.
In conclusion, we demonstrate that ferrylHb acts as a proin-
flammatory agonist in EC, suggesting that oxidation of cell-free
Hb and in particular production of ferrylHbmight be an impor-
tant component in the pathogenesis of inflammatory condi-
tions associated with hemolysis and EC activation such as is the
case for thrombotic microangiopathies.
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